Podcast: How a Long Effort to Protect Against RSV May Lead to a Better COVID-19 Vaccine

/ / , ,

Company to Watch – Meissa Vaccines

As part of July’s Company to Watch program, we spoke to Marty Moore, founder and CEO of Meissa Vaccines, about Meissa’s platform technology, how it works, and why its approach could provide significant benefits over existing COVID-19 vaccine.

 

NEXT: A Q&A with Ken Kelley, Chairperson of the Board for Meissa Vaccines

 

This is part of the Big4Bio Company to Watch program for July 2021: Meissa Vaccines.
For more information on the series, click here.